BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31145254)

  • 1. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Gastroenterol Nurs; 2019; 42(3):E3-E4. PubMed ID: 31145254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Old wine in new bottles: Lactulose works in hepatic encephalopathy].
    Bendtsen F
    Ugeskr Laeger; 2016 Oct; 178(42):. PubMed ID: 27745574
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 4. Home lactulose enema: prevention of hepatic encephalopathy at home.
    Saito T; Shinzawa H; Watanabe H; Togashi H; Kawata S
    J Gastroenterol; 2002 Jan; 37(1):68-9. PubMed ID: 11824804
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Tapper EB
    JAMA Intern Med; 2015 May; 175(5):868. PubMed ID: 25938321
    [No Abstract]   [Full Text] [Related]  

  • 6. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Cutler T; Mints G
    JAMA Intern Med; 2015 May; 175(5):867-8. PubMed ID: 25938320
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
    Rahimi RS; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2015 May; 175(5):868-9. PubMed ID: 25938322
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 10. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
    Huang E; Esrailian E; Spiegel BM
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gut solution for hepatic encephalopathy.
    Vaquero J; Bañares R
    Hepatology; 2015 Jun; 61(6):2107-009. PubMed ID: 25777043
    [No Abstract]   [Full Text] [Related]  

  • 13. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Sauerbruch T
    Dtsch Med Wochenschr; 2016 Aug; 141(17):1214. PubMed ID: 27557064
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
    Zucker DM; Redulla R
    Gastroenterol Nurs; 2019; 42(1):84-94. PubMed ID: 30688711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?].
    Nguyen-Tat M; Schattenberg JM
    Z Gastroenterol; 2015 Jul; 53(7):724-5. PubMed ID: 26167699
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain.
    Congly SE; Leise MD
    Am J Gastroenterol; 2014 Apr; 109(4):598. PubMed ID: 24698864
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyethylene glycol for hepatic encephalopathy: a new solution to purge an old problem?
    Doran AE; Shah NL
    JAMA Intern Med; 2014 Nov; 174(11):1734-5. PubMed ID: 25244573
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to Congly and Leise.
    Praveen S; Chander SB
    Am J Gastroenterol; 2014 Apr; 109(4):598-9. PubMed ID: 24698865
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Said VJ; Garcia-Trujillo E
    Gastroenterol Nurs; 2019; 42(3):277-285. PubMed ID: 31145253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.